FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16049211000001108: Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Nov 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
56651201000001114 Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
56651301000001117 Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 5 (CD Inv) true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets Is a Dihydrocodeine 30mg tablets 100 tablet true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets Has AMP Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets Has specific active ingredient Dihydrocodeine tartrate true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start